Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value
$2.86−0.14 (-4.67%)
Close on Nov 13, 2026Market cap $122.83MP/E –Yield –
Pulmonx operating margin
Operating margin is operating income as a percentage of revenue.
Pulmonx's operating margin for the twelve months ending Sep 30, 2026 was -44.4%. For fiscal 2025 it was -59.3%, against -68.9% the year before. The highest annual figure on record is -54.7% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -59.3% | +9.6 |
| FY2024 | Dec 31, 2024 | -68.9% | +21.3 |
| FY2023 | Dec 31, 2023 | -90.2% | +19.1 |
| FY2022 | Dec 31, 2022 | -109.3% | −11.6 |
| FY2021 | Dec 31, 2021 | -97.7% | +1.1 |
| FY2020 | Dec 31, 2020 | -98.8% | −44.0 |
| FY2019 | Dec 31, 2019 | -54.7% | +20.5 |
| FY2018 | Dec 31, 2018 | -75.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -32.8% | +34.1 |
| Q2 FY2026 | Jun 30, 2026 | -39.8% | +22.2 |
| Q1 FY2026 | Mar 31, 2026 | -62.9% | +1.7 |
| Q4 FY2025 | Dec 31, 2025 | -43.8% | +12.6 |
| Q3 FY2025 | Sep 30, 2025 | -66.9% | +2.4 |
| Q2 FY2025 | Jun 30, 2025 | -62.0% | +13.1 |
| Q1 FY2025 | Mar 31, 2025 | -64.6% | +12.5 |
| Q4 FY2024 | Dec 31, 2024 | -56.5% | +15.7 |
| Q3 FY2024 | Sep 30, 2024 | -69.3% | +16.6 |
| Q2 FY2024 | Jun 30, 2024 | -75.2% | +20.4 |
| Q1 FY2024 | Mar 31, 2024 | -77.1% | +35.7 |
| Q4 FY2023 | Dec 31, 2023 | -72.2% | +22.6 |
| Q3 FY2023 | Sep 30, 2023 | -85.9% | +17.3 |
| Q2 FY2023 | Jun 30, 2023 | -95.6% | +7.7 |
| Q1 FY2023 | Mar 31, 2023 | -112.8% | +32.4 |
| Q4 FY2022 | Dec 31, 2022 | -94.8% | −4.6 |
| Q3 FY2022 | Sep 30, 2022 | -103.2% | −29.6 |
| Q2 FY2022 | Jun 30, 2022 | -103.3% | +0.6 |
| Q1 FY2022 | Mar 31, 2022 | -145.3% | −10.1 |
| Q4 FY2021 | Dec 31, 2021 | -90.2% | +4.9 |
| Q3 FY2021 | Sep 30, 2021 | -73.6% | −23.2 |
| Q2 FY2021 | Jun 30, 2021 | -103.9% | +209.9 |
| Q1 FY2021 | Mar 31, 2021 | -135.2% | −64.3 |
| Q4 FY2020 | Dec 31, 2020 | -95.2% | −53.7 |
| Q3 FY2020 | Sep 30, 2020 | -50.4% | −10.7 |
| Q2 FY2020 | Jun 30, 2020 | -313.8% | – |
| Q1 FY2020 | Mar 31, 2020 | -70.8% | – |
| Q4 FY2019 | Dec 31, 2019 | -41.5% | – |
| Q3 FY2019 | Sep 30, 2019 | -39.7% | – |
See a number that looks wrong?